An experienced industry leader with more than 20 years of experience in drug discovery (medicinal chemistry) and early development including oversight of multi-functional teams spanning chemistry, biology, drug disposition/safety, process/analytical technologies, and laboratory management.

Shon currently serves as Vice President, Medicinal Chemistry at ROME Therapeutics, having previously served as Senior Director, Medical Chemistry at the company. Prior to joining ROME, Shon was Principal and Owner of SolTerra Consulting, LLC, where he advised companies on drug discovery programs leading to licensing of development candidates. Previously, he worked at Elanco, a global leader in animal health, where he held several roles of increasing responsibility over nine+ years, including most recently serving as Senior Director, Research Technologies. Prior to that, Shon was a Senior Research Chemist at D&M Continuous Solutions, LLC, a company that provides engineering, equipment, and chemistry consulting for continuous process development. Shon also previously served as Principal Research Scientist and, subsequently, Research Advisor with Eli Lilly and Company, as well as Research and Development Scientist at Pharmacia & Upjohn. Before beginning his industry career, Shon was an Assistant Professor of Organic Chemistry at the University of Missouri.

Shon graduated cum laude from Utah State University with a BS in Chemistry and earned his Ph.D. in chemistry from Colorado State University. He completed a post-doctoral fellowship in organic chemistry at Stanford University, and also received an Executive Certificate from the Kelly School of Business at Indiana University Bloomington.